Showing results (391-400 of 689) with videos related to
Sort By:
Pageof 69
Hypertension (Dallas, Tex. : 1979)|July 30, 2019
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 TrialSungha Park, Brian A Bergmark, Minggao Shi, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 24, 2016
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic SubstudyDeepak K Gupta, Robert P Giugliano, Christian T Ruff, et al.JAMA|August 11, 2000
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision makingE M Antman, M Cohen, P J Bernink, et al.European Heart Journal|December 28, 2018
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trialTze-Fan Chao, Shih-Ann Chen, Christian T Ruff, et al.JAMA Cardiology|October 6, 2016
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.European Heart Journal|May 15, 2015
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trialJ Steffel, R P Giugliano, E Braunwald, et al.The American Journal of Cardiology|July 13, 2004
Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteriesGraham S Gardner, Daniel R Frisch, Sabina A Murphy, et al.Circulation|May 25, 2011
Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)Willibald Hochholzer, Stephen D Wiviott, Elliott M Antman, et al.Journal of the American College of Cardiology|March 5, 2021
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial FibrillationJan Steffel, Christian T Ruff, Ophelia Yin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trialW P Peters, J P Eder, W D Henner, et al.Pageof 69